Latest Capital Raise News

Tetratherix Limited (ASX:TTX) has launched a $2 million share purchase plan offering eligible Australian and New Zealand shareholders the chance to buy shares at a 2% discount to recent trading prices. The non-underwritten SPP opens on 4 June and closes on 18 June 2026.

Careteq Limited’s strategic investor Antanas Guoga has converted all his convertible notes into shares, wiping out the company’s convertible debt and simplifying its capital structure ahead of its AI healthtech growth push.

Racura Oncology has secured $31.2 million in funding to advance its lead cancer drug RC220, including a strategic $1 million private placement to a specialist healthcare investor.

Tartana Minerals has kicked off an ambitious drilling program at its Tartana Copper Project aiming to more than double its contained copper resource beyond the existing open pit. Early drilling progress and operational upgrades signal a push toward expanding production and resource depth.

Arafura Rare Earths has officially opened its share purchase plan following ASIC lodgement, while also dispatching notices for a July extraordinary general meeting in Perth.

Range International has locked in a A$454,000 secured loan facility at 18% interest to ramp up its rental pallet fleet following early commercial success in 2026.

Lightning Minerals has locked in A$1.85 million through a two-tranche placement to accelerate drilling and exploration at its Mt Turner Gold Project, underpinning its strategic pivot to gold-led growth.

Variscan Mines is ramping up exploration at its Novales Project in northern Spain, advancing underground and surface drilling with infrastructure upgrades and capital raising support.

EQ Resources has secured board approval for a A$39 million expansion at its Mt Carbine tungsten mine, aiming to double crushing capacity and boost annual production by 500 tonnes amid strong tungsten prices.

Helios Energy has raised $1.5 million through a share placement priced at $0.003 per share while extinguishing $100,000 of convertible note debt by issuing shares, bolstering working capital.

Altitude Minerals is gearing up for significant drilling campaigns in New South Wales and Nevada, backed by a recent $1.15 million capital raise to fund exploration and project advancement.

Cynata Therapeutics secures a crucial regulatory green light from the EMA’s Paediatric Committee for its CYP-001 treatment in children with acute graft versus host disease, paving the way for sequential adult and paediatric trials in Europe.